entertainment -WSS

entertainment

author：comprehensive 2025-09-29 07:35:12 - browse：44383

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Ethical issues complicate the benefits of medical crowdfunding

WSS

House transparency, PBM reform bill gains bipartisan support

House transparency, PBM reform bill gains bipartisan support

Snackable artificial intelligence, expert AI, and the pharma industry

A rare thyroid diagnosis led to unexpected, all

NIH nominee Bertagnolli will get October confirmation hearing

AstraZeneca chief proposes a novel edit to the drug pricing bill

hotspot

entertainment

Sign up for D.C. Diagnosis

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Anesthesiologist group: stop taking Ozempic before surgery

Advances in CAR

Walensky prepares to leave CDC — and Congress — behind

CRISPR technology availability, affordability needs to be expanded

The high cost of giving birth even with insurance

Illumina names Agilent executive as new CEO

Wildfire smoke exposes gaps in outdoor worker protections

Illumina names Agilent executive as new CEO

explore

With Wegovy coverage, Medicare patients may face high costs

Medical devices makers are asking for forgiveness, not permission

Bring on the sabbaticals for nurses

CRISPR technology availability, affordability needs to be expanded

The 10 drugs up first for Medicare price negotiation

What drug price negotiations mean for Medicare Part D

hotspot

knowledge

explore

knowledge